Issue Archive
November 2005 | Volume 4 | Issue 6
Original Articles
Evidence Based or Theoretical Concern? The Alleged Acitretin Side Effects of Pseudotumor Cerebri and Depression
Oral retinoids are among the first line agents for treatment of pustular and erythrodermic psoriasis, and they are effective in combination with phototherapy and other topical and systemic agents for...
Read MoreFactors Affecting Prescription of Ultra-High Potency Topical Corticosteroids in Skin Disease: An Analysis of US National Practice Data
Of the topical preparations available, the ultra-high potency corticosteroids have an important role in treating psoriasis. However, the use of these agents in many other conditions and patient popul...
Read MoreImiquimod as an Antiangiogenic Agent
Imiquimod (imidazoquinoline 5%) is a topical immune response modifier agent that inhibits angiogenesis, the growth of new blood vessels. In addition to its stimulation of cell-mediated immunity, imiq...
Read MoreSafety and Efficacy of Alefacept in Elderly Patients and Other Special Populations
Background: The safety of biologic agents for psoriasis treatment is of particular importance in patient groups at higher risk for adverse events. We assessed the safety and efficacy of alefacept in ...
Read MoreCumulative Irritation Potential of Metronidazole Gel Compared to Azelaic Acid Gel after Repeated Applications to Healthy Skin
Background: Metronidazole 0.75% gel and azelaic acid 15% gel are commonly used to treat rosacea. Irritation is a common side effect.
Objective: To assess the cumulative irritation potential ...
Read MorePuerto Rico Psoriasis Study Group: Efficacy and Safety of Etanercept
Background:Although major advances in the understanding of its pathogenesis have been achieved, psoriasis remains an incurable disease. In April 2004, etanercept, an antagonist of TNF-?, was approved...
Read More
Features
Case Reports
Cystic Acne Improved by Photodynamic Therapy with Short-Contact 5-Aminolevulinic Acid and Sequential Combination of Intense Pulsed Light and Blue Light Activation
Photodynamic therapy with short-contact 5-aminolevulinic acid (Levulan® Kerastick®, Dusa Pharmaceuticals, Inc.) and activation by intense pulsed light in an initial treatment and blue light in ...
Read MoreBullous Pemphigoid following Therapy with an Oral Beta-Blocker
A causal relationship is thought to exist between several medications and the development of bullous pemphigoid. Commonly implicated medications include furosemide, penicillins, and ibuprofen. The fo...
Read MoreDermatofibrosarcoma Protuberans following Tanning Bed Use
Dermatofibrosarcoma protuberans (DFSP) is a rare, slowly growing, malignant dermal tumor first described by Darier and Ferrand in 1924.1 It typically occurs in individuals aged 20 to 40 years and fre...
Read MoreTolerance to Calcitriol and Tacalcitol in Three Patients with Allergic Contact Dermatitis to Calcipotriol
We describe 3 cases of psoriatic patients who developed a severe eczematous eruption after the use of calcipotriol ointment. For all of them, the dermatitis recovered after the suspension of the calc...
Read MoreTreatment of Erythematotelangiectactic Rosacea with a KTP YAG Laser
The flushing and telangiectasias associated with rosacea are notoriously difficult to treat with standard medications. Newer technologies, namely medical lasers and light sources, have made it possib...
Read MoreTrichophyton Tonsurans Associated Tinea Corporis Infection with the Development of Majocchi’s Granuloma in a Renal Transplant Patient
Trichophyton tonsurans is an uncommon cause of tinea corporis, and an even more uncommon cause of Majocchi’s granuloma. We report a patient who developed tinea corporis with Majocchi’s ...
Read MoreQ-Switched Alexandrite Laser-Assisted Treatment of Melasma: 2-Year Follow-up Monitoring
Melasma is a common disorder of hyperpigmentation involving sun exposed face and neck areas. Three clinical patterns of melasma are recognized: the centrofacial, the malar, and the mandibular ones. S...
Read More
Supplements
The Management of Skin and Skin Structure Infections: Guidelines for Prophylaxis and Treatment
This supplement to the Journal of Drugs in Dermatology was supported by Medicis Pharmaceutical Corp.....
Read More
